Potentiation of excitotoxicity in HIV-1-associated Dementia and the significance of glutaminase

被引:26
|
作者
Erdmann, Nathan B.
Whitney, Nicholas P.
Zheng, Jialin
机构
[1] Univ Nebraska, Med Ctr, Lab Neurotoxicol, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Ctr Neurovirol & Neurodegenerat Disorders, Omaha, NE 68198 USA
关键词
glutaminase; glutamate; excitotoxicity; macrophage; HIV-1-associated dementia; neurodegeneration;
D O I
10.1016/j.cnr.2006.09.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
HIV-1-associated Dementia (HAD) is a significant consequence of HIV infection. Although multiple inflammatory factors contribute to this chronic, progressive dementia, excitotoxic damage appears to be an underlying mechanism in the neurodegenerative process. Excitotoxicity is a cumulative effect of multiple processes occurring in the CNS during HAD. The overstimulation of glutamate receptors, an increased vulnerability of neurons, and disrupted astrocyte support each potentiate excitotoxic damage to neurons. Recent evidence suggests that poorly controlled generation of glutamate by phosphate-activated glutaminase may contribute to the neurotoxic state typical of HAD as well as other neurodegenerative disorders. Glutaminase converts glutamine, a widely available substrate throughout the CNS to glutamate. Inflammatory conditions may precipitate unregulated activity of glutaminase, a potentially important mechanism in HAD pathogenesis. (C) 2006 Association for Research in Nervous and Mental Disease. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:315 / 328
页数:14
相关论文
共 50 条
  • [1] Role for astrocytosis in HIV-1-associated dementia
    Vitkovic, L
    daCunha, A
    HIV AND DEMENTIA, 1995, 202 : 105 - 116
  • [2] NEUROBEHAVIORAL AND NEUROIMAGING CORRELATIONS IN HIV-1-ASSOCIATED DEMENTIA COMPILER
    ORTEGO, JN
    CHANG, L
    MILLER, BL
    OROPILLA, G
    MEYER, H
    SATZ, P
    MENA, I
    NEUROLOGY, 1994, 44 (04) : A248 - A248
  • [3] HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neuroimmunology
    Lawrence, DM
    Major, EO
    MICROBES AND INFECTION, 2002, 4 (03) : 301 - 308
  • [4] A proteomic fingerprint of cerebrospinal fluids from individuals with HIV-1-associated dementia
    Rozek, W.
    Holloway, S.
    Ricardo-Dukelow, M.
    Ciborowski, P.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S73 - S73
  • [5] Glutaminase Dysregulation in HIV-1-Infected Human Microglia Mediates Neurotoxicity: Relevant to HIV-1-Associated Neurocognitive Disorders
    Huang, Yunlong
    Zhao, Lixia
    Jia, Beibei
    Wu, Li
    Li, Yuju
    Curthoys, Norman
    Zheng, Jialin C.
    JOURNAL OF NEUROSCIENCE, 2011, 31 (42): : 15195 - 15204
  • [6] Relevance of glutamate levels in the CSF of patients with HIV-1-associated dementia complex
    Espey, MG
    Ellis, RJ
    Heaton, RK
    Basile, AS
    NEUROLOGY, 1999, 53 (05) : 1144 - 1145
  • [7] Neuronal survival and astrocyte-TIMP-1 regulation in HIV-1-associated dementia
    Ghorpade, Anuja
    Gardner, Jessica
    Chao, Clara
    Borgmann, Kathleen
    Persidsky, Raisa
    Wu, Li
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 216 - 216
  • [8] Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation: a mechanism for cognitive dysfunction in HIV-1-associated dementia
    Xiong, HG
    Zeng, YC
    Zheng, JL
    Thylin, M
    Gendelman, HE
    JOURNAL OF NEUROVIROLOGY, 1999, 5 (05) : 519 - 528
  • [9] HIV-1-associated encephalopathy and myelopathy
    Eggers, C
    NERVENARZT, 2000, 71 (08): : 677 - 684
  • [10] Sequence variation within the HIV-1 LTR correlates with brain regionalization and HIV-1-associated dementia
    Pitcher, Jonathan
    Nonnemacher, Michael R.
    Alexaki, Aikaterini
    Kilareski, Evelyn M.
    Gartner, Suzanne
    Wigdahl, Brian
    JOURNAL OF NEUROVIROLOGY, 2007, 13 : 115 - 115